| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/09/1994 | DE4240801A1 Staphylo-kinase (SAK) sequences lacking sequences for signal peptide(s) |
| 06/09/1994 | CA2592997A1 Pseudo-adenovirus vectors |
| 06/09/1994 | CA2151032A1 Activating expression of an amplifying endogenous gene by homologous recombination |
| 06/09/1994 | CA2150946A1 Treatment of dermatological malignancies with biologically active peptides |
| 06/09/1994 | CA2150554A1 Cyclodextrin and polymer based drug delivery system |
| 06/09/1994 | CA2150548A1 Therapeutic compounds suitable for the treatment of diseases connected with glutathione deficiency, process for their preparation, and pharmaceutical compositions containing same |
| 06/09/1994 | CA2150470A1 Polyunsaturated fatty acyl-peptide composition |
| 06/09/1994 | CA2150117A1 Interleukin-3 (il-3) mutant polypeptides |
| 06/09/1994 | CA2150116A1 Interleukin-3 (il-3) multiple mutation polypeptides |
| 06/09/1994 | CA2150028A1 Gp41 mutants and their use as hiv therapeutics |
| 06/09/1994 | CA2150027A1 Aids therapeutics based on hiv ma peptides |
| 06/09/1994 | CA2150025A1 Subtilin variant of enhanced stability and activity |
| 06/09/1994 | CA2149899A1 New oligopeptides with affinity to opioid receptors |
| 06/09/1994 | CA2149883A1 Cellular genes encoding retinoblastoma-associated proteins |
| 06/09/1994 | CA2149862A1 Multifunctional neurotrophic factors |
| 06/09/1994 | CA2149785A1 Antagonists of human gamma interferon |
| 06/09/1994 | CA2149763A1 Progenitor b cell stimulating factor |
| 06/09/1994 | CA2149635A1 Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors |
| 06/09/1994 | CA2149025A1 Humanized antibodies reactive with l-selectin |
| 06/09/1994 | CA2131023A1 Neurotrophic factor |
| 06/09/1994 | CA2128705A1 Method for producing soluble t-receptors by co-transfection, and use of resulting products |
| 06/09/1994 | CA2128694A1 Process for producing plasminogen-containing composition |
| 06/09/1994 | CA2127537A1 Use of fibroblast growth factors as neuroprotective and neuromodulatory agents |
| 06/08/1994 | EP0600745A1 The elucidation and synthesis of antineoplastic tetrapeptide phenethylamides of dolastatin 10 |
| 06/08/1994 | EP0600744A1 Tumor inhibiting tetrapeptide bearing modified phenethyl amides |
| 06/08/1994 | EP0600627A1 Human Id genes |
| 06/08/1994 | EP0600591A2 Inhibition of tumor cell growth by administration of B7-transfected cells |
| 06/08/1994 | EP0600396A2 Intestinal protozoal vaccines |
| 06/08/1994 | EP0600372A1 Process for the preparation of proinsulin with correctly linked cystin bridges |
| 06/08/1994 | EP0600278A2 Glutamate receptor protein and gene coding the same |
| 06/08/1994 | EP0600136A1 Intron/Exon structure of the human and mouse Beta 3 Adrenergic receptors genes |
| 06/08/1994 | EP0600079A1 ORAL 1$g(a)-HYDROXYPREVITAMIN D |
| 06/08/1994 | EP0600062A1 Polymer-bound paclitaxel derivatives |
| 06/08/1994 | EP0600010A1 Use of relaxin in cardiovascular therapy and in the treatment of neurodegenerative diseases |
| 06/08/1994 | EP0599983A1 Anti-hiv (aids) agents |
| 06/08/1994 | EP0599845A1 Medicament containing an agent inhibiting in vivo pathological apoptosis and applications thereof |
| 06/08/1994 | EP0583238A4 Modified pollen grains for delivering biologically active substances to plants and animals |
| 06/08/1994 | EP0557417A4 Compositions for reducing oxidative injury |
| 06/08/1994 | EP0531300B1 Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy |
| 06/08/1994 | EP0517789B1 Inhibitor of proliferation of endothelial cells |
| 06/08/1994 | EP0462194B1 Fibroblast growth factor (fgf)-based stabilized compositions |
| 06/08/1994 | EP0362209B1 New synthetic bioactive compounds and method of producing bioactive effect |
| 06/08/1994 | CN1087681A Novel antibodies for conferring passive immunity against infection by a pathogen in humans |
| 06/07/1994 | US5319072 Human antithrombin-III preparation |
| 06/07/1994 | US5318992 Inhibitors of nitric oxide biosynthesis |
| 06/07/1994 | US5318982 Inhibiting crosslinking of proteins |
| 06/07/1994 | US5318973 Administering a cyclo-(L-alanyl-1-amino-1-cyclopentane carbonyl) for head injury and ischemia |
| 06/07/1994 | US5318964 Hydroxamic derivatives and pharmaceutical compositions |
| 06/07/1994 | US5318958 Administering complex of high density lipoprotein and ligand having serum amyloid affinity for high density lipoproteins and promoting macrophage release of cholesterol for elimination |
| 06/07/1994 | US5318957 Administering a haptoglobin to a mammal; side effect reduction; cardiovascular disorders; antiischemic agents |
| 06/07/1994 | US5318901 Culturing TOLYPOCLADIUM in a nutrient containing 3-fluoro-alanine or 2-deutero-3-fluoro-alanine isotopes to get cyclic peptides immunosuppressants |
| 06/07/1994 | US5318899 Platelet aggregation inhibitors |
| 06/07/1994 | US5318890 Assays for inhibitors of leukocyte adhesion |
| 06/07/1994 | US5318778 Deodorizing lantibiotic cosmetic agents |
| 06/07/1994 | US5318524 Fibrin sealant delivery kit |
| 06/07/1994 | CA1330038C Methods and compositions for the use of hiv env polypeptides and antibodies thereto |
| 06/07/1994 | CA1330037C Treatment of cancer with somatostatin and analogs thereof |
| 06/07/1994 | CA1330036C Inhibition of arterial thrombotic occlusion or thromboembolism |
| 06/03/1994 | CA2110464A1 Guanidinyl-substituted heterocyclic thrombin inhibitors |
| 06/01/1994 | EP0599822A2 Method of preparation and use for zona pellucida antigens for sterilization and contraception |
| 06/01/1994 | EP0599444A1 Dual action inhibitors |
| 06/01/1994 | EP0599262A2 Stabilized superoxide-dismutase (SOD) compositions |
| 06/01/1994 | EP0598998A2 Humanized antibodies reacting with the ganglioside GM2 |
| 06/01/1994 | EP0598989A1 Nutritional composition and process for its preparation |
| 06/01/1994 | EP0598905A1 STABILIZED IL-1$g(a) PHARMACEUTICAL PREPARATION |
| 06/01/1994 | EP0598880A1 Salts of a glutathione alkylester and anaminoacids |
| 06/01/1994 | EP0598840A1 Human calcium channel compositions and methods |
| 06/01/1994 | EP0598839A1 Purine-region dna binding protein |
| 06/01/1994 | EP0598816A1 Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines |
| 06/01/1994 | EP0598813A1 Immunostimulation |
| 06/01/1994 | EP0598792A1 Osteoclast growth regulatory factor |
| 06/01/1994 | EP0598790A1 Somatotropin for increasing reproductivite performance in cattle. |
| 06/01/1994 | EP0598717A1 Duplex printer |
| 06/01/1994 | EP0596026A4 Antibiotic feed compositions and method of enhancing feed efficiency and promoting growth in monogastic animals |
| 06/01/1994 | EP0514544B1 Immune complexes |
| 06/01/1994 | EP0511202B1 A cell surface antigen associated with cellular apoptosis |
| 06/01/1994 | EP0479912B1 Inhibition of the n-end rule pathway in living cells |
| 06/01/1994 | EP0439458B1 Characterization and detection of sequences associated with autoimmune diseases |
| 06/01/1994 | EP0321481B1 Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals |
| 06/01/1994 | EP0302080B1 Human tachykinins and their precursors |
| 06/01/1994 | DE4239817A1 New protein tyrosine kinase and related nucleic acid - vectors, transformed cells, etc., useful for diagnosis and treatment of tumours |
| 06/01/1994 | DE4239816A1 Inhibiting glutamate-induced synaptic stimulus transfer - with specific spider toxins, for treating CNS disorders and characterisation of receptor channel sub-types |
| 06/01/1994 | DE4228458A1 Multicistronische Expressionseinheiten und deren Verwendung Multicistronic expression units and their use |
| 06/01/1994 | CN1087347A Novel sulfonamide inhibitors of aspartyl protease |
| 06/01/1994 | CN1087278A New use of lysozyme dimer and compositions containing the same |
| 06/01/1994 | CN1087277A Release-controlled somatotropin composition and method for prepartion thereof |
| 05/31/1994 | US5317097 DNA oligomers and genetic engineering |
| 05/31/1994 | US5317094 Detectors |
| 05/31/1994 | US5317089 Monoclonal antibodies against IFN-omega, processes for preparing them and their use in the purification and detection of IFN-omega |
| 05/31/1994 | US5317088 Binding |
| 05/31/1994 | US5317084 Process for large-scale production of antimicrobal peptide in high purity |
| 05/31/1994 | US5317017 N-biphenyl-3-amido substituted benzolactams stimulate growth hormone release |
| 05/31/1994 | US5317014 Peptides and pseudopeptides derived from tachykinin |
| 05/31/1994 | US5317012 Stimulants of immunology |
| 05/31/1994 | US5317011 Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses |
| 05/31/1994 | US5317010 Parathyroid hormone analogues substituted at AA 25, 26, 27, and use in osteoporosis treatment |
| 05/31/1994 | US5317009 Anti-HIV proteins GAP 31, DAP 30 and DAP 32 and therapeutic uses thereof |
| 05/31/1994 | US5316947 Synthetic isohirudins with improved stability |
| 05/31/1994 | US5316942 Slurrying insoluble collagen, adjustment of pH to dissolve, adding proteolytic enzymes and water |
| 05/31/1994 | US5316937 Conditioned medium useful for sustaining growth of colonic crypt cells |